Senores Pharmaceuticals Rs 830
Senores Pharmaceuticals is an emerging, US-focused specialty pharma and CDMO platform that stands apart from typical Indian generic exporters. While the stock is not inexpensive at current valuations, it offers a differentiated growth profile driven by regulated-market exposure, complex generics, long-tenure US government contracts, and a rapidly scaling CDMO business.
